Alport Syndrome Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Video
• Funding
• Clinical Trials

Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS)
Condition:   Alport Syndrome, X-Linked Interventions:   Drug: Hydroxychloroquine Sulfate 100 milligram (mg) Tab;   Drug: Benazepril hydrochloride 10 milligram (mg) Tab Sponsor:   Shanghai Children's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 24, 2021 Category: Research Source Type: clinical trials

A Study of RG-012 in Subjects With Alport Syndrome
Condition:   Alport Syndrome Intervention:   Drug: RG012 Sponsor:   Regulus Therapeutics Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2017 Category: Research Source Type: clinical trials